 | • レポートコード：MRC308GR11423 • 出版社/出版日：GlobalInfoResearch / 2023年8月 • レポート形態：英文、PDF、129ページ • 納品方法：Eメール（2-3営業日） • 産業分類：医薬品＆ヘルスケア |
| Single User | ￥522,000 (USD3,480) | ▷ お問い合わせ |
| Corporate User | ￥783,000 (USD5,220) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
GlobalInfoResearchの最新の調査によると、世界の好酸球増加症用治療の市場規模は2022年のxxx米ドルから2029年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。新型コロナウイルス感染症とロシア・ウクライナ戦争の影響を考慮しながら市場規模を推計しました。
このレポートは、世界の好酸球増加症用治療市場に関する詳細かつ包括的な分析の結果です。定量的分析と定性的分析データが、メーカー別、地域別、国別、種類別、用途別に記載されています。
市場は常に変化しているため、本レポートでは、競争、需要と供給の傾向、および多くの市場にわたる需要の変化に影響する主要な要因を調査しました。主要な競合他社の企業概要と製品例、および2023年の市場シェア予測も記載しました。
本レポートの主な目的は次のとおりです。
– 世界および主要国の市場機会の規模を決定するため
– 好酸球増加症用治療の成長可能性を評価するため
– 各製品および最終用途市場の将来の成長を予測するため
– 市場に影響を与える競争要因を評価するため
好酸球増加症用治療市場は種類と用途によって区分されます。2018年～2029年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。
種類別セグメント
・経口式、静脈注射式
用途別セグメント
・病院薬局、小売薬局、オンライン薬局
主要な市場プレーヤー
・Pfizer Inc.、Novartis AG、Merck & Co., Inc.、Eli Lilly and Company、AstraZeneca、Bayer AG、Sanofi、Takeda Pharmaceutical Company Limited、Hoffmann-La Roche Ltd、GlaxoSmithKline plc、Gilead Sciences, Inc.、GSK、Sanofi、Johnson and Johnson、LEO Pharma、Sumitomo、Cipla、Abbott Laboratories、Zizhu Pharma、Regeneron Pharmaceuticals, Inc.
地域別セグメントは次の地域・国をカバーします。
・北米（米国、カナダ、メキシコ）
・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南アメリカ（ブラジル、アルゼンチン、コロンビア）
・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ）
本調査レポートの内容は計15章あります。
・第1章では、好酸球増加症用治療製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要な好酸球増加症用治療メーカーの企業概要、2019年～2022年までの好酸球増加症用治療の価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要な好酸球増加症用治療メーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2018年～2029年までの地域別好酸球増加症用治療の販売量、売上、成長性を示しています。
・第5、6章では、2018年～2029年までの好酸球増加症用治療の種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2018年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2029年までの主要地域での好酸球増加症用治療市場予測を収録しています。
・第12章では、市場力学、成長要因、阻害要因、トレンド、ポーターズファイブフォース分析、新型コロナウイルス感染症とロシア・ウクライナ戦争の影響を掲載しています。
・第13章では、主要な原材料、主要なサプライヤー、および好酸球増加症用治療の産業チェーンを掲載しています。
・第14、15章では、好酸球増加症用治療の販売チャネル、販売業者、顧客、調査結果について説明します。
***** 目次(一部) *****
・市場概要
– 好酸球増加症用治療の概要
– 種類別分析（2018年vs2022年vs2029年）：経口式、静脈注射式
– 用途別分析（2018年vs2022年vs2029年）：病院薬局、小売薬局、オンライン薬局
– 世界の好酸球増加症用治療市場規模・予測
– 世界の好酸球増加症用治療生産能力分析
– 市場の成長要因・阻害要因・動向
・メーカー情報（企業概要、製品概要、販売量、価格、売上）
– Pfizer Inc.、Novartis AG、Merck & Co., Inc.、Eli Lilly and Company、AstraZeneca、Bayer AG、Sanofi、Takeda Pharmaceutical Company Limited、Hoffmann-La Roche Ltd、GlaxoSmithKline plc、Gilead Sciences, Inc.、GSK、Sanofi、Johnson and Johnson、LEO Pharma、Sumitomo、Cipla、Abbott Laboratories、Zizhu Pharma、Regeneron Pharmaceuticals, Inc.
・メーカー別市場シェア・市場集中度
・地域別市場分析2018年-2029年
・種類別分析2018年-2029年：経口式、静脈注射式
・用途別分析2018年-2029年：病院薬局、小売薬局、オンライン薬局
・好酸球増加症用治療の北米市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：アメリカ、カナダ、メキシコなど
・好酸球増加症用治療のヨーロッパ市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど
・好酸球増加症用治療のアジア市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど
・好酸球増加症用治療の南米市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：ブラジル、アルゼンチンなど
・好酸球増加症用治療の中東・アフリカ市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど
・市場力学（成長要因、阻害要因、トレンド、ポーターズファイブフォース分析）
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論
1 Market Overview
1.1 Product Overview and Scope of Eosinophilia Treatment
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Eosinophilia Treatment Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Oral
1.3.3 Intravenous
1.4 Market Analysis by Application
1.4.1 Overview: Global Eosinophilia Treatment Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Hospital Pharmacy
1.4.3 Retail Pharmacy
1.4.4 Online Pharmacy
1.5 Global Eosinophilia Treatment Market Size & Forecast
1.5.1 Global Eosinophilia Treatment Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Eosinophilia Treatment Sales Quantity (2018-2029)
1.5.3 Global Eosinophilia Treatment Average Price (2018-2029)
2 Manufacturers Profiles
2.1 Pfizer Inc.
2.1.1 Pfizer Inc. Details
2.1.2 Pfizer Inc. Major Business
2.1.3 Pfizer Inc. Eosinophilia Treatment Product and Services
2.1.4 Pfizer Inc. Eosinophilia Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Pfizer Inc. Recent Developments/Updates
2.2 Novartis AG
2.2.1 Novartis AG Details
2.2.2 Novartis AG Major Business
2.2.3 Novartis AG Eosinophilia Treatment Product and Services
2.2.4 Novartis AG Eosinophilia Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Novartis AG Recent Developments/Updates
2.3 Merck & Co., Inc.
2.3.1 Merck & Co., Inc. Details
2.3.2 Merck & Co., Inc. Major Business
2.3.3 Merck & Co., Inc. Eosinophilia Treatment Product and Services
2.3.4 Merck & Co., Inc. Eosinophilia Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Merck & Co., Inc. Recent Developments/Updates
2.4 Eli Lilly and Company
2.4.1 Eli Lilly and Company Details
2.4.2 Eli Lilly and Company Major Business
2.4.3 Eli Lilly and Company Eosinophilia Treatment Product and Services
2.4.4 Eli Lilly and Company Eosinophilia Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Eli Lilly and Company Recent Developments/Updates
2.5 AstraZeneca
2.5.1 AstraZeneca Details
2.5.2 AstraZeneca Major Business
2.5.3 AstraZeneca Eosinophilia Treatment Product and Services
2.5.4 AstraZeneca Eosinophilia Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 AstraZeneca Recent Developments/Updates
2.6 Bayer AG
2.6.1 Bayer AG Details
2.6.2 Bayer AG Major Business
2.6.3 Bayer AG Eosinophilia Treatment Product and Services
2.6.4 Bayer AG Eosinophilia Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Bayer AG Recent Developments/Updates
2.7 Sanofi
2.7.1 Sanofi Details
2.7.2 Sanofi Major Business
2.7.3 Sanofi Eosinophilia Treatment Product and Services
2.7.4 Sanofi Eosinophilia Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Sanofi Recent Developments/Updates
2.8 Takeda Pharmaceutical Company Limited
2.8.1 Takeda Pharmaceutical Company Limited Details
2.8.2 Takeda Pharmaceutical Company Limited Major Business
2.8.3 Takeda Pharmaceutical Company Limited Eosinophilia Treatment Product and Services
2.8.4 Takeda Pharmaceutical Company Limited Eosinophilia Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Takeda Pharmaceutical Company Limited Recent Developments/Updates
2.9 Hoffmann-La Roche Ltd
2.9.1 Hoffmann-La Roche Ltd Details
2.9.2 Hoffmann-La Roche Ltd Major Business
2.9.3 Hoffmann-La Roche Ltd Eosinophilia Treatment Product and Services
2.9.4 Hoffmann-La Roche Ltd Eosinophilia Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Hoffmann-La Roche Ltd Recent Developments/Updates
2.10 GlaxoSmithKline plc
2.10.1 GlaxoSmithKline plc Details
2.10.2 GlaxoSmithKline plc Major Business
2.10.3 GlaxoSmithKline plc Eosinophilia Treatment Product and Services
2.10.4 GlaxoSmithKline plc Eosinophilia Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 GlaxoSmithKline plc Recent Developments/Updates
2.11 Gilead Sciences, Inc.
2.11.1 Gilead Sciences, Inc. Details
2.11.2 Gilead Sciences, Inc. Major Business
2.11.3 Gilead Sciences, Inc. Eosinophilia Treatment Product and Services
2.11.4 Gilead Sciences, Inc. Eosinophilia Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 Gilead Sciences, Inc. Recent Developments/Updates
2.12 GSK
2.12.1 GSK Details
2.12.2 GSK Major Business
2.12.3 GSK Eosinophilia Treatment Product and Services
2.12.4 GSK Eosinophilia Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 GSK Recent Developments/Updates
2.13 Sanofi
2.13.1 Sanofi Details
2.13.2 Sanofi Major Business
2.13.3 Sanofi Eosinophilia Treatment Product and Services
2.13.4 Sanofi Eosinophilia Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 Sanofi Recent Developments/Updates
2.14 Johnson and Johnson
2.14.1 Johnson and Johnson Details
2.14.2 Johnson and Johnson Major Business
2.14.3 Johnson and Johnson Eosinophilia Treatment Product and Services
2.14.4 Johnson and Johnson Eosinophilia Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.14.5 Johnson and Johnson Recent Developments/Updates
2.15 LEO Pharma
2.15.1 LEO Pharma Details
2.15.2 LEO Pharma Major Business
2.15.3 LEO Pharma Eosinophilia Treatment Product and Services
2.15.4 LEO Pharma Eosinophilia Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.15.5 LEO Pharma Recent Developments/Updates
2.16 Sumitomo
2.16.1 Sumitomo Details
2.16.2 Sumitomo Major Business
2.16.3 Sumitomo Eosinophilia Treatment Product and Services
2.16.4 Sumitomo Eosinophilia Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.16.5 Sumitomo Recent Developments/Updates
2.17 Cipla
2.17.1 Cipla Details
2.17.2 Cipla Major Business
2.17.3 Cipla Eosinophilia Treatment Product and Services
2.17.4 Cipla Eosinophilia Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.17.5 Cipla Recent Developments/Updates
2.18 Abbott Laboratories
2.18.1 Abbott Laboratories Details
2.18.2 Abbott Laboratories Major Business
2.18.3 Abbott Laboratories Eosinophilia Treatment Product and Services
2.18.4 Abbott Laboratories Eosinophilia Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.18.5 Abbott Laboratories Recent Developments/Updates
2.19 Zizhu Pharma
2.19.1 Zizhu Pharma Details
2.19.2 Zizhu Pharma Major Business
2.19.3 Zizhu Pharma Eosinophilia Treatment Product and Services
2.19.4 Zizhu Pharma Eosinophilia Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.19.5 Zizhu Pharma Recent Developments/Updates
2.20 Regeneron Pharmaceuticals, Inc.
2.20.1 Regeneron Pharmaceuticals, Inc. Details
2.20.2 Regeneron Pharmaceuticals, Inc. Major Business
2.20.3 Regeneron Pharmaceuticals, Inc. Eosinophilia Treatment Product and Services
2.20.4 Regeneron Pharmaceuticals, Inc. Eosinophilia Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.20.5 Regeneron Pharmaceuticals, Inc. Recent Developments/Updates
3 Competitive Environment: Eosinophilia Treatment by Manufacturer
3.1 Global Eosinophilia Treatment Sales Quantity by Manufacturer (2018-2023)
3.2 Global Eosinophilia Treatment Revenue by Manufacturer (2018-2023)
3.3 Global Eosinophilia Treatment Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Eosinophilia Treatment by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Eosinophilia Treatment Manufacturer Market Share in 2022
3.4.2 Top 6 Eosinophilia Treatment Manufacturer Market Share in 2022
3.5 Eosinophilia Treatment Market: Overall Company Footprint Analysis
3.5.1 Eosinophilia Treatment Market: Region Footprint
3.5.2 Eosinophilia Treatment Market: Company Product Type Footprint
3.5.3 Eosinophilia Treatment Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Eosinophilia Treatment Market Size by Region
4.1.1 Global Eosinophilia Treatment Sales Quantity by Region (2018-2029)
4.1.2 Global Eosinophilia Treatment Consumption Value by Region (2018-2029)
4.1.3 Global Eosinophilia Treatment Average Price by Region (2018-2029)
4.2 North America Eosinophilia Treatment Consumption Value (2018-2029)
4.3 Europe Eosinophilia Treatment Consumption Value (2018-2029)
4.4 Asia-Pacific Eosinophilia Treatment Consumption Value (2018-2029)
4.5 South America Eosinophilia Treatment Consumption Value (2018-2029)
4.6 Middle East and Africa Eosinophilia Treatment Consumption Value (2018-2029)
5 Market Segment by Type
5.1 Global Eosinophilia Treatment Sales Quantity by Type (2018-2029)
5.2 Global Eosinophilia Treatment Consumption Value by Type (2018-2029)
5.3 Global Eosinophilia Treatment Average Price by Type (2018-2029)
6 Market Segment by Application
6.1 Global Eosinophilia Treatment Sales Quantity by Application (2018-2029)
6.2 Global Eosinophilia Treatment Consumption Value by Application (2018-2029)
6.3 Global Eosinophilia Treatment Average Price by Application (2018-2029)
7 North America
7.1 North America Eosinophilia Treatment Sales Quantity by Type (2018-2029)
7.2 North America Eosinophilia Treatment Sales Quantity by Application (2018-2029)
7.3 North America Eosinophilia Treatment Market Size by Country
7.3.1 North America Eosinophilia Treatment Sales Quantity by Country (2018-2029)
7.3.2 North America Eosinophilia Treatment Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 Europe
8.1 Europe Eosinophilia Treatment Sales Quantity by Type (2018-2029)
8.2 Europe Eosinophilia Treatment Sales Quantity by Application (2018-2029)
8.3 Europe Eosinophilia Treatment Market Size by Country
8.3.1 Europe Eosinophilia Treatment Sales Quantity by Country (2018-2029)
8.3.2 Europe Eosinophilia Treatment Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 Asia-Pacific
9.1 Asia-Pacific Eosinophilia Treatment Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Eosinophilia Treatment Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Eosinophilia Treatment Market Size by Region
9.3.1 Asia-Pacific Eosinophilia Treatment Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Eosinophilia Treatment Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 South America
10.1 South America Eosinophilia Treatment Sales Quantity by Type (2018-2029)
10.2 South America Eosinophilia Treatment Sales Quantity by Application (2018-2029)
10.3 South America Eosinophilia Treatment Market Size by Country
10.3.1 South America Eosinophilia Treatment Sales Quantity by Country (2018-2029)
10.3.2 South America Eosinophilia Treatment Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 Middle East & Africa
11.1 Middle East & Africa Eosinophilia Treatment Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Eosinophilia Treatment Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Eosinophilia Treatment Market Size by Country
11.3.1 Middle East & Africa Eosinophilia Treatment Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Eosinophilia Treatment Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 Market Dynamics
12.1 Eosinophilia Treatment Market Drivers
12.2 Eosinophilia Treatment Market Restraints
12.3 Eosinophilia Treatment Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 Raw Material and Industry Chain
13.1 Raw Material of Eosinophilia Treatment and Key Manufacturers
13.2 Manufacturing Costs Percentage of Eosinophilia Treatment
13.3 Eosinophilia Treatment Production Process
13.4 Eosinophilia Treatment Industrial Chain
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Eosinophilia Treatment Typical Distributors
14.3 Eosinophilia Treatment Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
Table 1. Global Eosinophilia Treatment Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Eosinophilia Treatment Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Pfizer Inc. Basic Information, Manufacturing Base and Competitors
Table 4. Pfizer Inc. Major Business
Table 5. Pfizer Inc. Eosinophilia Treatment Product and Services
Table 6. Pfizer Inc. Eosinophilia Treatment Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. Pfizer Inc. Recent Developments/Updates
Table 8. Novartis AG Basic Information, Manufacturing Base and Competitors
Table 9. Novartis AG Major Business
Table 10. Novartis AG Eosinophilia Treatment Product and Services
Table 11. Novartis AG Eosinophilia Treatment Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. Novartis AG Recent Developments/Updates
Table 13. Merck & Co., Inc. Basic Information, Manufacturing Base and Competitors
Table 14. Merck & Co., Inc. Major Business
Table 15. Merck & Co., Inc. Eosinophilia Treatment Product and Services
Table 16. Merck & Co., Inc. Eosinophilia Treatment Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. Merck & Co., Inc. Recent Developments/Updates
Table 18. Eli Lilly and Company Basic Information, Manufacturing Base and Competitors
Table 19. Eli Lilly and Company Major Business
Table 20. Eli Lilly and Company Eosinophilia Treatment Product and Services
Table 21. Eli Lilly and Company Eosinophilia Treatment Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. Eli Lilly and Company Recent Developments/Updates
Table 23. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 24. AstraZeneca Major Business
Table 25. AstraZeneca Eosinophilia Treatment Product and Services
Table 26. AstraZeneca Eosinophilia Treatment Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. AstraZeneca Recent Developments/Updates
Table 28. Bayer AG Basic Information, Manufacturing Base and Competitors
Table 29. Bayer AG Major Business
Table 30. Bayer AG Eosinophilia Treatment Product and Services
Table 31. Bayer AG Eosinophilia Treatment Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. Bayer AG Recent Developments/Updates
Table 33. Sanofi Basic Information, Manufacturing Base and Competitors
Table 34. Sanofi Major Business
Table 35. Sanofi Eosinophilia Treatment Product and Services
Table 36. Sanofi Eosinophilia Treatment Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. Sanofi Recent Developments/Updates
Table 38. Takeda Pharmaceutical Company Limited Basic Information, Manufacturing Base and Competitors
Table 39. Takeda Pharmaceutical Company Limited Major Business
Table 40. Takeda Pharmaceutical Company Limited Eosinophilia Treatment Product and Services
Table 41. Takeda Pharmaceutical Company Limited Eosinophilia Treatment Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. Takeda Pharmaceutical Company Limited Recent Developments/Updates
Table 43. Hoffmann-La Roche Ltd Basic Information, Manufacturing Base and Competitors
Table 44. Hoffmann-La Roche Ltd Major Business
Table 45. Hoffmann-La Roche Ltd Eosinophilia Treatment Product and Services
Table 46. Hoffmann-La Roche Ltd Eosinophilia Treatment Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 47. Hoffmann-La Roche Ltd Recent Developments/Updates
Table 48. GlaxoSmithKline plc Basic Information, Manufacturing Base and Competitors
Table 49. GlaxoSmithKline plc Major Business
Table 50. GlaxoSmithKline plc Eosinophilia Treatment Product and Services
Table 51. GlaxoSmithKline plc Eosinophilia Treatment Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 52. GlaxoSmithKline plc Recent Developments/Updates
Table 53. Gilead Sciences, Inc. Basic Information, Manufacturing Base and Competitors
Table 54. Gilead Sciences, Inc. Major Business
Table 55. Gilead Sciences, Inc. Eosinophilia Treatment Product and Services
Table 56. Gilead Sciences, Inc. Eosinophilia Treatment Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 57. Gilead Sciences, Inc. Recent Developments/Updates
Table 58. GSK Basic Information, Manufacturing Base and Competitors
Table 59. GSK Major Business
Table 60. GSK Eosinophilia Treatment Product and Services
Table 61. GSK Eosinophilia Treatment Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 62. GSK Recent Developments/Updates
Table 63. Sanofi Basic Information, Manufacturing Base and Competitors
Table 64. Sanofi Major Business
Table 65. Sanofi Eosinophilia Treatment Product and Services
Table 66. Sanofi Eosinophilia Treatment Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 67. Sanofi Recent Developments/Updates
Table 68. Johnson and Johnson Basic Information, Manufacturing Base and Competitors
Table 69. Johnson and Johnson Major Business
Table 70. Johnson and Johnson Eosinophilia Treatment Product and Services
Table 71. Johnson and Johnson Eosinophilia Treatment Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 72. Johnson and Johnson Recent Developments/Updates
Table 73. LEO Pharma Basic Information, Manufacturing Base and Competitors
Table 74. LEO Pharma Major Business
Table 75. LEO Pharma Eosinophilia Treatment Product and Services
Table 76. LEO Pharma Eosinophilia Treatment Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. LEO Pharma Recent Developments/Updates
Table 78. Sumitomo Basic Information, Manufacturing Base and Competitors
Table 79. Sumitomo Major Business
Table 80. Sumitomo Eosinophilia Treatment Product and Services
Table 81. Sumitomo Eosinophilia Treatment Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 82. Sumitomo Recent Developments/Updates
Table 83. Cipla Basic Information, Manufacturing Base and Competitors
Table 84. Cipla Major Business
Table 85. Cipla Eosinophilia Treatment Product and Services
Table 86. Cipla Eosinophilia Treatment Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 87. Cipla Recent Developments/Updates
Table 88. Abbott Laboratories Basic Information, Manufacturing Base and Competitors
Table 89. Abbott Laboratories Major Business
Table 90. Abbott Laboratories Eosinophilia Treatment Product and Services
Table 91. Abbott Laboratories Eosinophilia Treatment Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 92. Abbott Laboratories Recent Developments/Updates
Table 93. Zizhu Pharma Basic Information, Manufacturing Base and Competitors
Table 94. Zizhu Pharma Major Business
Table 95. Zizhu Pharma Eosinophilia Treatment Product and Services
Table 96. Zizhu Pharma Eosinophilia Treatment Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 97. Zizhu Pharma Recent Developments/Updates
Table 98. Regeneron Pharmaceuticals, Inc. Basic Information, Manufacturing Base and Competitors
Table 99. Regeneron Pharmaceuticals, Inc. Major Business
Table 100. Regeneron Pharmaceuticals, Inc. Eosinophilia Treatment Product and Services
Table 101. Regeneron Pharmaceuticals, Inc. Eosinophilia Treatment Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 102. Regeneron Pharmaceuticals, Inc. Recent Developments/Updates
Table 103. Global Eosinophilia Treatment Sales Quantity by Manufacturer (2018-2023) & (K Units)
Table 104. Global Eosinophilia Treatment Revenue by Manufacturer (2018-2023) & (USD Million)
Table 105. Global Eosinophilia Treatment Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 106. Market Position of Manufacturers in Eosinophilia Treatment, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 107. Head Office and Eosinophilia Treatment Production Site of Key Manufacturer
Table 108. Eosinophilia Treatment Market: Company Product Type Footprint
Table 109. Eosinophilia Treatment Market: Company Product Application Footprint
Table 110. Eosinophilia Treatment New Market Entrants and Barriers to Market Entry
Table 111. Eosinophilia Treatment Mergers, Acquisition, Agreements, and Collaborations
Table 112. Global Eosinophilia Treatment Sales Quantity by Region (2018-2023) & (K Units)
Table 113. Global Eosinophilia Treatment Sales Quantity by Region (2024-2029) & (K Units)
Table 114. Global Eosinophilia Treatment Consumption Value by Region (2018-2023) & (USD Million)
Table 115. Global Eosinophilia Treatment Consumption Value by Region (2024-2029) & (USD Million)
Table 116. Global Eosinophilia Treatment Average Price by Region (2018-2023) & (US$/Unit)
Table 117. Global Eosinophilia Treatment Average Price by Region (2024-2029) & (US$/Unit)
Table 118. Global Eosinophilia Treatment Sales Quantity by Type (2018-2023) & (K Units)
Table 119. Global Eosinophilia Treatment Sales Quantity by Type (2024-2029) & (K Units)
Table 120. Global Eosinophilia Treatment Consumption Value by Type (2018-2023) & (USD Million)
Table 121. Global Eosinophilia Treatment Consumption Value by Type (2024-2029) & (USD Million)
Table 122. Global Eosinophilia Treatment Average Price by Type (2018-2023) & (US$/Unit)
Table 123. Global Eosinophilia Treatment Average Price by Type (2024-2029) & (US$/Unit)
Table 124. Global Eosinophilia Treatment Sales Quantity by Application (2018-2023) & (K Units)
Table 125. Global Eosinophilia Treatment Sales Quantity by Application (2024-2029) & (K Units)
Table 126. Global Eosinophilia Treatment Consumption Value by Application (2018-2023) & (USD Million)
Table 127. Global Eosinophilia Treatment Consumption Value by Application (2024-2029) & (USD Million)
Table 128. Global Eosinophilia Treatment Average Price by Application (2018-2023) & (US$/Unit)
Table 129. Global Eosinophilia Treatment Average Price by Application (2024-2029) & (US$/Unit)
Table 130. North America Eosinophilia Treatment Sales Quantity by Type (2018-2023) & (K Units)
Table 131. North America Eosinophilia Treatment Sales Quantity by Type (2024-2029) & (K Units)
Table 132. North America Eosinophilia Treatment Sales Quantity by Application (2018-2023) & (K Units)
Table 133. North America Eosinophilia Treatment Sales Quantity by Application (2024-2029) & (K Units)
Table 134. North America Eosinophilia Treatment Sales Quantity by Country (2018-2023) & (K Units)
Table 135. North America Eosinophilia Treatment Sales Quantity by Country (2024-2029) & (K Units)
Table 136. North America Eosinophilia Treatment Consumption Value by Country (2018-2023) & (USD Million)
Table 137. North America Eosinophilia Treatment Consumption Value by Country (2024-2029) & (USD Million)
Table 138. Europe Eosinophilia Treatment Sales Quantity by Type (2018-2023) & (K Units)
Table 139. Europe Eosinophilia Treatment Sales Quantity by Type (2024-2029) & (K Units)
Table 140. Europe Eosinophilia Treatment Sales Quantity by Application (2018-2023) & (K Units)
Table 141. Europe Eosinophilia Treatment Sales Quantity by Application (2024-2029) & (K Units)
Table 142. Europe Eosinophilia Treatment Sales Quantity by Country (2018-2023) & (K Units)
Table 143. Europe Eosinophilia Treatment Sales Quantity by Country (2024-2029) & (K Units)
Table 144. Europe Eosinophilia Treatment Consumption Value by Country (2018-2023) & (USD Million)
Table 145. Europe Eosinophilia Treatment Consumption Value by Country (2024-2029) & (USD Million)
Table 146. Asia-Pacific Eosinophilia Treatment Sales Quantity by Type (2018-2023) & (K Units)
Table 147. Asia-Pacific Eosinophilia Treatment Sales Quantity by Type (2024-2029) & (K Units)
Table 148. Asia-Pacific Eosinophilia Treatment Sales Quantity by Application (2018-2023) & (K Units)
Table 149. Asia-Pacific Eosinophilia Treatment Sales Quantity by Application (2024-2029) & (K Units)
Table 150. Asia-Pacific Eosinophilia Treatment Sales Quantity by Region (2018-2023) & (K Units)
Table 151. Asia-Pacific Eosinophilia Treatment Sales Quantity by Region (2024-2029) & (K Units)
Table 152. Asia-Pacific Eosinophilia Treatment Consumption Value by Region (2018-2023) & (USD Million)
Table 153. Asia-Pacific Eosinophilia Treatment Consumption Value by Region (2024-2029) & (USD Million)
Table 154. South America Eosinophilia Treatment Sales Quantity by Type (2018-2023) & (K Units)
Table 155. South America Eosinophilia Treatment Sales Quantity by Type (2024-2029) & (K Units)
Table 156. South America Eosinophilia Treatment Sales Quantity by Application (2018-2023) & (K Units)
Table 157. South America Eosinophilia Treatment Sales Quantity by Application (2024-2029) & (K Units)
Table 158. South America Eosinophilia Treatment Sales Quantity by Country (2018-2023) & (K Units)
Table 159. South America Eosinophilia Treatment Sales Quantity by Country (2024-2029) & (K Units)
Table 160. South America Eosinophilia Treatment Consumption Value by Country (2018-2023) & (USD Million)
Table 161. South America Eosinophilia Treatment Consumption Value by Country (2024-2029) & (USD Million)
Table 162. Middle East & Africa Eosinophilia Treatment Sales Quantity by Type (2018-2023) & (K Units)
Table 163. Middle East & Africa Eosinophilia Treatment Sales Quantity by Type (2024-2029) & (K Units)
Table 164. Middle East & Africa Eosinophilia Treatment Sales Quantity by Application (2018-2023) & (K Units)
Table 165. Middle East & Africa Eosinophilia Treatment Sales Quantity by Application (2024-2029) & (K Units)
Table 166. Middle East & Africa Eosinophilia Treatment Sales Quantity by Region (2018-2023) & (K Units)
Table 167. Middle East & Africa Eosinophilia Treatment Sales Quantity by Region (2024-2029) & (K Units)
Table 168. Middle East & Africa Eosinophilia Treatment Consumption Value by Region (2018-2023) & (USD Million)
Table 169. Middle East & Africa Eosinophilia Treatment Consumption Value by Region (2024-2029) & (USD Million)
Table 170. Eosinophilia Treatment Raw Material
Table 171. Key Manufacturers of Eosinophilia Treatment Raw Materials
Table 172. Eosinophilia Treatment Typical Distributors
Table 173. Eosinophilia Treatment Typical Customers
List of Figures
Figure 1. Eosinophilia Treatment Picture
Figure 2. Global Eosinophilia Treatment Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Eosinophilia Treatment Consumption Value Market Share by Type in 2022
Figure 4. Oral Examples
Figure 5. Intravenous Examples
Figure 6. Global Eosinophilia Treatment Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 7. Global Eosinophilia Treatment Consumption Value Market Share by Application in 2022
Figure 8. Hospital Pharmacy Examples
Figure 9. Retail Pharmacy Examples
Figure 10. Online Pharmacy Examples
Figure 11. Global Eosinophilia Treatment Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 12. Global Eosinophilia Treatment Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 13. Global Eosinophilia Treatment Sales Quantity (2018-2029) & (K Units)
Figure 14. Global Eosinophilia Treatment Average Price (2018-2029) & (US$/Unit)
Figure 15. Global Eosinophilia Treatment Sales Quantity Market Share by Manufacturer in 2022
Figure 16. Global Eosinophilia Treatment Consumption Value Market Share by Manufacturer in 2022
Figure 17. Producer Shipments of Eosinophilia Treatment by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 18. Top 3 Eosinophilia Treatment Manufacturer (Consumption Value) Market Share in 2022
Figure 19. Top 6 Eosinophilia Treatment Manufacturer (Consumption Value) Market Share in 2022
Figure 20. Global Eosinophilia Treatment Sales Quantity Market Share by Region (2018-2029)
Figure 21. Global Eosinophilia Treatment Consumption Value Market Share by Region (2018-2029)
Figure 22. North America Eosinophilia Treatment Consumption Value (2018-2029) & (USD Million)
Figure 23. Europe Eosinophilia Treatment Consumption Value (2018-2029) & (USD Million)
Figure 24. Asia-Pacific Eosinophilia Treatment Consumption Value (2018-2029) & (USD Million)
Figure 25. South America Eosinophilia Treatment Consumption Value (2018-2029) & (USD Million)
Figure 26. Middle East & Africa Eosinophilia Treatment Consumption Value (2018-2029) & (USD Million)
Figure 27. Global Eosinophilia Treatment Sales Quantity Market Share by Type (2018-2029)
Figure 28. Global Eosinophilia Treatment Consumption Value Market Share by Type (2018-2029)
Figure 29. Global Eosinophilia Treatment Average Price by Type (2018-2029) & (US$/Unit)
Figure 30. Global Eosinophilia Treatment Sales Quantity Market Share by Application (2018-2029)
Figure 31. Global Eosinophilia Treatment Consumption Value Market Share by Application (2018-2029)
Figure 32. Global Eosinophilia Treatment Average Price by Application (2018-2029) & (US$/Unit)
Figure 33. North America Eosinophilia Treatment Sales Quantity Market Share by Type (2018-2029)
Figure 34. North America Eosinophilia Treatment Sales Quantity Market Share by Application (2018-2029)
Figure 35. North America Eosinophilia Treatment Sales Quantity Market Share by Country (2018-2029)
Figure 36. North America Eosinophilia Treatment Consumption Value Market Share by Country (2018-2029)
Figure 37. United States Eosinophilia Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 38. Canada Eosinophilia Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 39. Mexico Eosinophilia Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 40. Europe Eosinophilia Treatment Sales Quantity Market Share by Type (2018-2029)
Figure 41. Europe Eosinophilia Treatment Sales Quantity Market Share by Application (2018-2029)
Figure 42. Europe Eosinophilia Treatment Sales Quantity Market Share by Country (2018-2029)
Figure 43. Europe Eosinophilia Treatment Consumption Value Market Share by Country (2018-2029)
Figure 44. Germany Eosinophilia Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 45. France Eosinophilia Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 46. United Kingdom Eosinophilia Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 47. Russia Eosinophilia Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. Italy Eosinophilia Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 49. Asia-Pacific Eosinophilia Treatment Sales Quantity Market Share by Type (2018-2029)
Figure 50. Asia-Pacific Eosinophilia Treatment Sales Quantity Market Share by Application (2018-2029)
Figure 51. Asia-Pacific Eosinophilia Treatment Sales Quantity Market Share by Region (2018-2029)
Figure 52. Asia-Pacific Eosinophilia Treatment Consumption Value Market Share by Region (2018-2029)
Figure 53. China Eosinophilia Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 54. Japan Eosinophilia Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 55. Korea Eosinophilia Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 56. India Eosinophilia Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. Southeast Asia Eosinophilia Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. Australia Eosinophilia Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 59. South America Eosinophilia Treatment Sales Quantity Market Share by Type (2018-2029)
Figure 60. South America Eosinophilia Treatment Sales Quantity Market Share by Application (2018-2029)
Figure 61. South America Eosinophilia Treatment Sales Quantity Market Share by Country (2018-2029)
Figure 62. South America Eosinophilia Treatment Consumption Value Market Share by Country (2018-2029)
Figure 63. Brazil Eosinophilia Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 64. Argentina Eosinophilia Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 65. Middle East & Africa Eosinophilia Treatment Sales Quantity Market Share by Type (2018-2029)
Figure 66. Middle East & Africa Eosinophilia Treatment Sales Quantity Market Share by Application (2018-2029)
Figure 67. Middle East & Africa Eosinophilia Treatment Sales Quantity Market Share by Region (2018-2029)
Figure 68. Middle East & Africa Eosinophilia Treatment Consumption Value Market Share by Region (2018-2029)
Figure 69. Turkey Eosinophilia Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 70. Egypt Eosinophilia Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 71. Saudi Arabia Eosinophilia Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 72. South Africa Eosinophilia Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 73. Eosinophilia Treatment Market Drivers
Figure 74. Eosinophilia Treatment Market Restraints
Figure 75. Eosinophilia Treatment Market Trends
Figure 76. Porters Five Forces Analysis
Figure 77. Manufacturing Cost Structure Analysis of Eosinophilia Treatment in 2022
Figure 78. Manufacturing Process Analysis of Eosinophilia Treatment
Figure 79. Eosinophilia Treatment Industrial Chain
Figure 80. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 81. Direct Channel Pros & Cons
Figure 82. Indirect Channel Pros & Cons
Figure 83. Methodology
Figure 84. Research Process and Data Source